Survey of Canadian Physician Use of Botulinum Toxin A (BoNT-A) for Paratonia: Real World Insights
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2025
DOI: 10.1017/cjn.2024.46 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2025. Verfasst von Galit Kleiner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Austin Centre for Neurology and Behavioral Supports, Baycrest Health Sciences, Katz Interprofessional Research Program in Geriatric Dementia Care, Ro…. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Neuromuscular Agents, Muscle Hypertonia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Paratonia is a form of hypertonia characterized by an inability to relax muscles in the setting of cognitive impairment. Paratonia results in pain, refusal of care, and caregiver burden. We sent surveys to 67 Canadian physiatrists and neurologists regarding their experience treating paratonia with botulinum toxin A (BoNT-A). Twenty-seven survey respondents were included in the analysis. Thirteen percent of survey respondents treating paratonia with BoNT-A reported a significant clinically relevant improvement; 74% endorsed a moderately clinically relevant improvement; 13% endorsed a slight clinically relevant improvement. Ninety percent of survey respondents endorsed significant barriers in treating paratonia with BoNT-A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Austin Centre for Neurology and Behavioral Supports, Baycrest Health Sciences, Katz Interprofessional Research Program in Geriatric Dementia Care, Rotman Research Institute, Toronto, ON, Canada.
- Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
- West Park Health Care Center, Toronto, ON, Canada.
- Division of Physiatry, Department of Medicine, University of Toronto, Toronto, ON, Canada.
- Hotel Dieu Shaver Health and Rehabilitation Centre, St. Catherine's, ON, Canada.
- Division of Physiatry, Dept of Medicine, McMaster University, St. Catherine's, ON, Canada.
ORCID-Profile: Galit Kleiner
Zitieren
APA
Kleiner, G., Ismail, F., Khan, O., Pilieci, C., Truong, L., & Boulias, C. (2025). Survey of Canadian Physician Use of Botulinum Toxin A (BoNT-A) for Paratonia: Real World Insights. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/cjn.2024.46
Vancouver
Kleiner G, Ismail F, Khan O, Pilieci C, Truong L, Boulias C. Survey of Canadian Physician Use of Botulinum Toxin A (BoNT-A) for Paratonia: Real World Insights. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2025. doi:10.1017/cjn.2024.46
BibTeX
@article{Kleiner2025,
author = {Kleiner, Galit and Ismail, Farooq and Khan, Omar and Pilieci, Christopher and Truong, Linda and Boulias, Chris},
title = {Survey of Canadian Physician Use of Botulinum Toxin A (BoNT-A) for Paratonia: Real World Insights},
journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
year = {2025},
doi = {10.1017/cjn.2024.46}
}
EUVIMED